Lucy Scientific Discovery Inc.
LSDIF
$0.0002
$0.000.00%
OTC PK
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 377.09% | 82.27% | 136.67% | 116.52% | -76.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 379.23% | 82.27% | 137.18% | 116.52% | -76.16% |
| Operating Income | -373.90% | -82.27% | -136.38% | -116.52% | 76.16% |
| Income Before Tax | -95.37% | -45.67% | -96.25% | -145.84% | 56.47% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -95.37% | -45.67% | -96.25% | -145.84% | 56.47% |
| Earnings from Discontinued Operations | -393.73% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -180.52% | -45.67% | -96.25% | -145.84% | 39.08% |
| EBIT | -373.90% | -82.27% | -136.38% | -116.52% | 76.16% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -66.03% | 13.48% | -25.43% | -84.72% | 40.85% |
| Normalized Basic EPS | 29.49% | 17.68% | -21.78% | -31.50% | 57.73% |
| EPS Diluted | -66.03% | 13.48% | -25.43% | -84.72% | 40.85% |
| Normalized Diluted EPS | 29.49% | 17.68% | -21.78% | -31.50% | 57.73% |
| Average Basic Shares Outstanding | 68.96% | 68.34% | 56.45% | 33.08% | 3.00% |
| Average Diluted Shares Outstanding | 68.96% | 68.34% | 56.45% | 33.08% | 3.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |